Ortega‐Paz, L., Cristóbal, H., Ortiz‐Perez, J. T., García de Frutos, P., Mendieta, G., Sandoval, E., . . . Dantas, A. P. (2023). Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction. ESC Heart Failure, 10(1), 453-464. https://doi.org/10.1002/ehf2.14186
Chicago Style (17th ed.) CitationOrtega‐Paz, Luis, et al. "Direct Actions of Dapagliflozin and Interactions with LCZ696 and Spironolactone on Cardiac Fibroblasts of Patients with Heart Failure and Reduced Ejection Fraction." ESC Heart Failure 10, no. 1 (2023): 453-464. https://doi.org/10.1002/ehf2.14186.
MLA (9th ed.) CitationOrtega‐Paz, Luis, et al. "Direct Actions of Dapagliflozin and Interactions with LCZ696 and Spironolactone on Cardiac Fibroblasts of Patients with Heart Failure and Reduced Ejection Fraction." ESC Heart Failure, vol. 10, no. 1, 2023, pp. 453-464, https://doi.org/10.1002/ehf2.14186.